Correlation Between Hookipa Pharma and Boundless Bio,

Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Boundless Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Boundless Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hookipa Pharma and Boundless Bio, Common, you can compare the effects of market volatilities on Hookipa Pharma and Boundless Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Boundless Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Boundless Bio,.

Diversification Opportunities for Hookipa Pharma and Boundless Bio,

0.69

Correlation Coefficient

Hookipa Pharma  Boundless Bio,

Poor diversification

The 3 months correlation between Hookipa and Boundless is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Boundless Bio, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boundless Bio, Common and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Boundless Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boundless Bio, Common has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Boundless Bio, go up and down completely randomly.

Pair Corralation between Hookipa Pharma and Boundless Bio,

Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Boundless Bio,. But the stock apears to be less risky and, when comparing its historical volatility, Hookipa Pharma is 1.39 times less risky than Boundless Bio,. The stock trades about -0.36 of its potential returns per unit of risk. The Boundless Bio, Common is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  300.00  in Boundless Bio, Common on September 26, 2024 and sell it today you would lose (42.00) from holding Boundless Bio, Common or give up 14.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Hookipa Pharma  vs.  Boundless Bio, Common

Hookipa Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hookipa Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Boundless Bio, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Boundless Bio, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Hookipa Pharma and Boundless Bio,

The main advantage of trading using opposite Hookipa Pharma and Boundless Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Boundless Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boundless Bio, will offset losses from the drop in Boundless Bio,'s long position.

The idea behind Hookipa Pharma and Boundless Bio, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.